Loading
Latest filing published 26 Nov 2018 for Arbutus Biopharma Corporation.
No signal scores available.
Frank Torti appears in our data through filings on Arbutus Biopharma Corporation shares, published by SEDI. Altogether 2 filings, all relating to 26 November 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 26 November 2018: a transaction, in Arbutus Biopharma Corporation. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations